Clinical Trial Update: Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Lantus (insulin glargine) and Apidra (insulin glulisine) in patients with acute myocardial infarction was terminated, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Apidra (insulin glulisine)
• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: AMI | Phase 3 | Status: TERMINATED | Results posted: 2011-02-11